Roderich E. Schwarz MD

Roderich Schwarz

Roderich E. Schwarz
MD

Contact Information
Roswell Park Cancer Institute
Elm and Carlton Streets
Buffalo, NY 14263
Phone: (214) 537-0498
roderich@buffalo.edu



Professional Summary:

I was exposed to the field of surgery through my ancestry, as my grandfather and great-grandfather were surgeons. I knew that I wanted to be a surgeon from an early age, and during medical school I always had the surgical field in mind. Helping patients through gastrointestinal cancer treatments and operations has been my passion and focus for almost 40 years. A cancer diagnosis is a tremendous challenge for anyone. Within a single day, it can turn someone's world upside down. Being able to help patients who are in that situation, both as a physician and as a surgeon, is very important to me. Cancer treatment is not only about treating the tumor in the best possible way, but helping the patient and the family cope with the situation and guiding them through it.

I began my medical education in Germany and continued my training, research and clinical work in the United States at various well-respected cancer centers, including the University of Pittsburgh, Memorial Sloan-Kettering Cancer Center, City of Hope in California, the Cancer Institute of New Jersey, the Simmons Comprehensive Cancer Center at UT Southwestern in Texas and most recently at Indiana University with the Goshen Center for Cancer Care, before coming to Buffalo, NY. After having worked at a total of five National Cancer Institute-designated comprehensive cancer centers, I consider it a true privilege to now hold a leadership role at a center like Roswell Park that set the model for other cancer centers to follow over a century ago.

My clinical interest is in pancreatic, hepatobiliary and upper GI tract cancer. My laboratory-based translational activities focus on experimental combination therapy of pancreatic and gastric cancer. I am a member of 13 scientific organizations, including the American College of Surgeons (ACS), American Association for Cancer Research (AACR), Society of Surgical Oncology (SSO), Americas Hepato-Pancreato-Biliary Association (AHPBA) and Society of University Surgeons (SUS), and have served as committee member or chair and as executive council member on several of these. I am also recognized as an exceptional clinician member of the "Best Doctors in America" and "America's Top Surgeons" databases, and as an outstanding teacher through several academic teaching awards.

Employment:

  • Professor, Surgery, Roswell Park Cancer Institute (2018-present)
  • Professor of Surgery, Surgery, Indiana University, School of Medicine (2013-present)
  • Medical Director, Goshen Center for Cancer Care (2013–2018)
  • Mark and Jane Gibson Distinguished Professor of Cancer Research, UT Southwestern Medical School (2008–2013)
  • Division of Surgical Oncology, UT Southwestern Simmons Comprehensive Cancer Center, UT Southwestern Medical School (2007–2013)

Awards and Honors:

  • Traveller's Grant Award to the 101st Annual Congress (2001)
  • Surgical Oncology Fellows Operative Teaching Award (1999)
  • Poster of Distinction award (1998)
  • NIH-K12 Fellow Research Award (1998)
  • Best Poster Presentation Award (1995)
  • Deutsche Forschungsgemeinschaft (DFG) (1987)
  • Clinical Fellowship Abroad award (1985)
  • The Welcome Trust: British subinternship exchange travel award (1983)


Journal Articles:

See all (100 more)

Books and Book Chapters:

  • Nelson, RA, Smith, DD, Schwarz RE. Epidemiology and Staging of Upper Gastrointestinal Cancer, Chapter 84. 2018.
  • Schwarz RE. Esophagogastric Junction Cancer: Definition, Staging Aspects, Therapeutic Implications. Chapter 92, Upper Gastrointestinal Cancer Section. 2018.
  • von Holzen, UW, Mansour, JC, Schwarz RE. Multimodality Therapy of Gastric Cancer: Western Experience. Chapter 100, Upper Gastrointestinal Cancer Section. 2018.
  • von Holzen, UW, Mansour, JC, Schwarz RE. Surgical emergencies in the thrombocytopenic or anticoagulated cancer patient, Chapter 4. 2016.
  • Ostapoff, KT, Awasthi, N, Dellinger, M, Brekken, RD, Schwarz RE. Modeling pancreatic cancer in vivo.. 2014.
  • Schwarz RE. Standards for Surgical Therapy of Gastric Cancer. 2014.
  • Konduri, S, Schwarz RE. Estrogen receptor implications in human pancreatic cancer.. 2010.
  • Blanke, CD, Citrin, D, Schwarz RE. Gastric Cancer, chapter 10. 2010.
  • Blanke, CD, Citrin, D, Schwarz RE. Gastric Cancer, Chapter 13. 2008.
  • August, DA, Kearnery, T, Schwarz RE. General oncologic surgical emergencies. Chapter 73. 2006.
  • Bonin, SR, Schwarz RE, Blanke, CD, Coia, LR, Hoff, PM. Gastric Cancer Chapter 13. 2001.
  • Schwarz RE, Karpeh, MS, Brennan, MF. Surgical management of gastric cancer: the Western experience.. 1999.
  • Schwarz RE, Grannis, FW. Thoracoscopic lung resections in the treatment of pulmonary malignancies.. 1998.
  • Coia, LR, Bonin, SR, Diaz-Canton, EA, Pazdur, R, Schwarz RE. Gastric Cancer-chapter 5. 1998.
  • Harrison, LE, Schwarz RE, Karpeh, MS, Brennan, MF. Total gastrectomy is not necessary for proximal gastric cancer.. 1997.
  • Schwarz RE, Klimstra, DS, Turnbull, ADM. Gastric cancer masqueraded by metastatic breast cancer: a differential diagnostic challenge.. 1997.
  • Schwarz RE, Karpeh, MS, Brennan, MF. Impact of complications on hospitalization and survival after operative treatment of gastric cancer in elderly patients.. 1997.
  • Schwarz RE, Posner, MC. Tumor Biology. 1994.
  • Schwarz RE, Felgar, RE, Hiserodt, JC. Successful adoptive immunotherapy of established lung and liver metastases with highly purified IL-2 activated natural killer cells (ALAK cells).. 1990.
  • Schwarz RE. Ssurface structures involved in tumor cell recognition by fresh and IL-2 activated natural killer cells. 1988.
  • Schwarz RE. Laminin-like p48: a surface structure involved in target cell recognition by non-MHC-restricted cytotoxic effector cells.. 1988.
  • Minarich, MJ, von Holzen, UW, Schwarz RE. Surgical therapy and appropriate lymphadenectomy for GE junction cancer...
See all (12 more)

Evaluative Studies and Case Reports:

See all (17 more)

Presentations:

  • "Administration of Endothelial Monocyte Activating Polypeptide (EMAP II) function blocking antibody rescues alveolarization, decreases cellular proliferation and reduces apoptosis in bronchopulmonary dysplasia (BPD)" American Academy of Pediatrics Annual Meeting (2012)
  • "Heparanase inhibition reduces tumor growth and metastasis in pancreatic ductal adenocarcinoma by inducing hypoxia and inhibiting collagen deposition" American College of Surgeons (2012)
  • "nhibition of stromal TGFβR2 reduces pancreatic cancer growth and metastasis in vivo" American College of Surgeons (2012)
  • "Single-fraction stereotactic radiation of liver metastases: preliminary results of a phase I trial" American Society for Radiation Oncology (2012)
  • "A phase II study of bavituximab and sorafenib in advanced hepatocellular carcinoma" American Society of Clinical Oncology Annual Meeting (2012)
  • "Factors associated with perioperative outcomes following resection of retroperitoneal tumors" 14th Annual UT Southwestern Surgical Research Forum (2012)
  • "Factors associated with readmission following complex hepato-pancreato-biliary operations" 14th Annual UT Southwestern Surgical Research Forum (2012)
  • "A phase I study of bavituximab and sorafenib in advanced hepatocellular carcinoma" American Association for Cancer Research (2012)
  • "Antitumor activity of BMS-754807, a small molecule inhibitor of insulin-like growth factor-1 receptor / insulin receptor, in combination with gemcitabine in pancreatic cancer" American Association for Cancer Research (2012)
  • "Apricoxib enhances response to standard therapy and promotes mesenchymal to epithelial transition in preclinical models of pancreatic cancer" 65th Annual Cancer Symposium, Society of Surgical Oncology (2012)
  • "Effect of 2G8, a TGF-beta-R2 inhibitor, on TGF-beta signaling and migration in an immunocompetent pancreatic cancer model" Society of Surgical Oncology 65th Annual Cancer Symposium (2012)
  • "Epithelial-mesenchymal transition increases tumor sensitivity to COX-2 inhibition" 65th Annual Cancer Symposium, Society of Surgical Oncology (2012)
  • "Exploration of enhancing pancreatic cancer targeted combination therapy through antiendothelial EMAP II" Americas Hepato Pancreato Biliary Association 12th Annual Meeting (2012)
  • "Factors associated with readmission following complex hepato-pancreato-biliary operations" Americas Hepato Pancreato Biliary Association 12th Annual Meeting (2012)
  • "Initial experience with a comprehensive tissue biobanking program focusing on complex gastrointestinal cancer resections" Americas Hepato Pancreato Biliary Association 12th Annual Meeting (2012)
  • "NVP-BEZ235, a dual PI3K/mTOR inhibitor, enhances chemotherapy and antiangiogenic response in pancreatic cancer" Society of SurgicalOncology 65th Annual Cancer Symposium (2012)
  • "PG545, a heparanase inhibitor, inhibits pancreatic cancer tumor cell proliferation in vitro and tumor progression in vivo" Society of Surgical Oncology 65th Annual Cancer Symposium (2012)
  • "AXL receptor tyrosine kinase is critical to pancreatic cancer progression and metastases" 51st AXL receptor tyrosine kinase is critical to pancreatic cancer progression and metastases, Annual Meeting of the North Texas Chapter (2012)
  • "Axl receptor tyrosine kinase is essential to pancreatic tumor progression and metastases" 7th Annual Academic Surgical Congress (2012)
  • "Comparison of tissue preservation methods and resulting RNA quality in gastrointestinal tumors and associated benign tissues" 5th Annual Biospecimen Research Network (BRN) Symposium: Research Through Biospecimen Science (2012)
  • "Factors associated with perioperative outcomes following resection of retroperitoneal tumors" American College of Surgeons, 51st Annual Meeting of the North Texas Chapter (2012)
  • "Factors associated with readmission following complex hepato-pancreato-biliary operations" American College of Surgeons,, 51st Annual Meeting of the North Texas Chapter (2012)
  • "Initial experience with a comprehensive tissue biobanking program focusing on complex gastrointestinal cancer resections" American College of Surgeons, 51st Annual Meeting of the North Texas Chapter (2012)
  • "PG545, a heparanase inhibitor, inhibits pancreatic cancer tumor cell proliferation in vitro and tumor progression in vivo" 51st, Annual Meeting of the North Texas Chapter (2012)
  • "Plexiform neurofibromatosis of the liver" American College of Surgeons, 51st Annual Meeting of the North Texas Chapter (2012)
  • "Potential factors to explain decreased survival of Blacks and Hispanics with gastroesophageal adenocarcinoma" American College of Surgeons, 51st Annual Meeting of the North Texas Chapter (2012)
  • "Effect of 2G8, a TGF-beta-R2 inhibitor, on TGF-beta signaling and migration in an immunocompetent pancreatic cancer model" 2012 Gastrointestinal Cancers Symposium (ASCO-GI) (2012)
  • "Evaluation of combination treatment benefits of nab-paclitaxel in experimental pancreatic cancer." 2012 Gastrointestinal Cancers Symposium (ASCO-GI) (2012)
  • "NVP-BEZ235, a dual PI3K/mTOR inhibitor, enhances chemotherapy and antiangiogenic response in pancreatic cancer" 2012 Gastrointestinal Cancers Symposium (ASCO-GI) (2012)
  • "PG545, a heparanase inhibitor, inhibits pancreatic cancer tumor cell proliferation in vitro and tumor progression in vivo" 2012 Gastrointestinal Cancers Symposium (ASCO-GI) (2012)
  • "Potential factors to explain decreased survival for ethnic subgroups with gastroesophageal adenocarcinoma (poster presentation," 2012 Gastrointestinal Cancers Symposium (ASCO-GI) (2012)
  • "The predictive value of POSSUM scoring in postoperative complications of patients with cancer and complex gastrointestinal surgical conditions" UT Southwestern Students Research Forum (2012)
  • "Dosimetric and motion analysis of margin-intensive radiation delivery by stereotactic body radiation therapy for operable pancreatic cancer" American Society for Radiation Oncology (2011)
  • "Preclinical antitumor activity and mechanisms of action of apricoxib, a COX-2 inhibitor" 97th Annual Clinical Congress of the American College of Surgeons (2011)
  • "Analysis of quality parameters for early postoperative outcomes after hepatic resections" 13th Annual UT Southwestern Surgical Research Forum (2011)
  • "Analysis of quality parameters for early postoperative outcomes after hepatic resections" 13th Annual UT Southwestern Surgical Research Forum (2011)
  • "Enhancement of chemotherapeutic efficacy by combination of targeted antiangiogennic therapies in experimental pancreatic cancer" 13th Annual UT Southwestern Surgical Research Forum (2011)
  • "Malignant pancreatic cystic neoplasms: histopathologic subtypes and associated survival outcomes" 13th Annual UT Southwestern Surgical Research Forum (2011)
  • "Margin-intense stereotactic irradiation as preoperative adjuvant therapy for pancreatic cancer" 13th Annual UT Southwestern Surgical Research Forum (2011)
  • "NVP-BEZ235, a novel dual PI3-Kinase/mTOR inhibitor, enhances antitumor combination therapy effects against pancreatic cancer" 13th Annual UT Southwestern Surgical Research Forum (2011)
  • "Smac mimetic improves response to gemcitabine and docetaxel in experimental pancreatic cancer" 13th Annual UT Southwestern Surgical Research Forum (2011)
  • "Total pancreatoduodenectomy with portal venous resection for locoregionally advanced pancreatic neuroendocine tumor." 13th Annual UT Southwestern Surgical Research Forum (2011)
  • "Augmentation of antiangiogenic therapies to enhance gemcitabine response in pancreatic cancer" American Association for Cancer Research (2011)
  • "Antitumor activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer" American Hepato Pancreato Biliary Association 11th Annual Meeting, March (2011)
  • "Inhibition of COX-2 with apricoxib significantly enhances the efficacy of standard therapy in preclinical models of human pancreatic cancer" Society of Surgical Oncology's 64th Annual Cancer Symposium (2011)
  • "NVP-BEZ235, a novel dual PI3-Kinase/mTOR inhibitor, enhances antitumor combination therapy effects against pancreatic cancer" Society of Surgical Oncology's 64th Annual Cancer Symposium (2011)
  • "Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes" American Hepato Pancreato Biliary Association 11th Annual Meeting (2011)
  • "The impact of ethnic group background on presentation and outcomes for patients with gastroesophageal adenocarcinoma" Society of Surgical Oncology's 64th Annual Cancer Symposium (2011)
  • "Analysis of quality parameters for early postoperative outcomes after hepatic resections" 50th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2011)
  • "Attempts to enhance gemcitabine effects by antiangiogenic therapies in pancreatic cancer" 6th Annual Academic Surgical Congress (2011)
  • "Initiation and early experience of a multispecialty approach to pelvic exenterations for cancer" 50th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2011)
  • "Malignant pancreatic cystic neoplasms: histopathologic subtypes and associated survival outcomes" 50th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2011)
  • "Margin-intense stereotactic irradiation as preoperative adjuvant therapy for pancreatic cancer" 50th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2011)
  • "Prediction of malignancy risk for patients with dominant splenic lesions" 50th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2011)
  • "Robotic assisted low anterior resection for a distal rectal cancer: a video presentation" 50th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2011)
  • "Smac mimetic improves response to gemcitabine and docetaxel in experimental pancreatic cancer" 6th Annual Academic Surgical Congress (2011)
  • "Total pancreatoduodenectomy with portal venous resection for locoregionally advanced pancreatic neuroendocrine tumor" 50th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2011)
  • "Use of the liver hanging maneuver for resection of a large adrenocortical carcinoma" 50th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2011)
  • "A comparison of competing lymph node staging schemes in resectable biliary cancer" 2011 Gastrointestinal Cancers Symposium (2011)
  • "Activity of a novel dual PI3-Kinase/mTOR inhibitor NVP-BEZ235 to enhance antitumor activities of gemcitabine and EMAP II in pancreatic cancer" 2011 Gastrointestinal Cancers Symposium (2011)
  • "Inhibition of COX-2 with apricoxib significantly enhances the efficacy of standard therapy in preclinical models of human pancreatic cancer" 2011 Gastrointestinal CancersSymposium (2011)
  • "Enhancing cytotoxic agent activity through EMAP II combination therapy in experimental pancreatic cancer" Cancer prevention and research Institute of Texas Innovations in Cancer Prevention and Research Conference (2010)
  • "Combination treatment benefits of EMAP II with doxorubicin, docetaxel and gemcitabine in experimental pancreatic cancer" 12th Annual UT Southwestern Surgical Research Forum (2010)
  • "Experience with a simplified feeding jejunostomy technique for enteral nutrition following major visceral procedures" 12th Annual UT Southwestern Surgical Research Forum. (2010)
  • "Prediction of malignancy risk for patients with splenic mass lesions (poster presentation" 12th Annual UT Southwestern Surgical Research Forum (2010)
  • "Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes" 12th Annual UT Southwestern Surgical Research Forum (2010)
  • "A comparison of competing lymph node staging schemes in resectable biliary cancer" 9th World Congress of the International Hepato-Pancreato-Biliary Association IHPBA (2010)
  • "Combination treatment benefits of EMAP II with doxorubicin, docetaxel and gemcitabine in experimental pancreatic cancer" American Association for Cancer Research 101st Annual Meeting (2010)
  • "A combination approach to enhance taxane-based antitumor activity in experimental pancreatic cancer" 63rd Annual Cancer Symposium, Society for Surgical Oncology (2010)
  • "A comparison of competing lymph node staging schemes in resectable gastric cancer" Society for Surgical Oncology, 63rd Annual Cancer Symposium (2010)
  • "Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer" 63rd Annual Cancer Symposium, Society for Surgical Oncology (2010)
  • "Is timing to delivery of treatment a reliable measure of quality of care for patients with colorectal adenocarcinoma?" Society for Surgical Oncology 63rd Annual Cancer Symposium (2010)
  • "Case report of leiomyosarcoma of the inferior vena cava in a Jehovah’s Witness" 49th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2010)
  • "Combination effects of bortezomib with gemcitabine and EMAP II in experimental pancreatic cancer" 5th Annual Academic Surgical Congress (2010)
  • "Effects of combination of EMAP II with doxorubicin, docetaxel, oxaliplatin and gemcitabine to enhance antitumor activity in pancreatic cancer" 5th Annual Academic Surgical Congress (2010)
  • "Effects of the Smac Mimetic JP1201 to enhance antitumor activities of gemcitabine and EMAP II in experimental pancreatic cancer" 5th Annual Academic Surgical Congress (2010)
  • "Experience with a simplified feeding jejunostomy technique for enteral nutrition following major visceral procedures" 49th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2010)
  • "Graded histologic response after neoadjuvant chemoradiotherapy and surgical resection for gastroesophageal junction cancer" 49th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2010)
  • "Intraduodenal sarcoma recurrence: an unusual cause for duodenal obstruction" 49th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2010)
  • "Liver resection improves survival for non-metastatic gallbladder cancer: a 10-year review" 2010 Gastrointestinal Cancers Symposium (2010)
  • "Operative therapy of adrenocortical carcinoma with right atrial thrombus extension: a case report" Annual Meeting of the North Texas Chapter of the American College of Surgeons (2010)
  • "Positron emission tomography is beneficial in the preoperative evaluation of patients with colorectal cancer recurrences" 49th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2010)
  • "Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes" 49th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2010)
  • "A comparison of competing lymph node staging schemes in resectable gastric cancer" 2010 Gastrointestinal Cancers Symposium (2010)
  • "11th UT Southwestern Surgical Research Forum" 11th UT Southwestern Surgical Research Forum (2009)
  • "Impact of clinical and diagnostic characteristics on a surgical approach to retroperitoneal mass lesions" 11th UT Southwestern Surgical Research Forum (2009)
  • "Operative predictors of early postgastrectomy outcomes, and their impact on long-term survival" 11th UT Southwestern Surgical Research Forum (2009)
  • "Survival impact of malignant pancreatic islet cell neoplasm phenotypes" Digestive Disease Week (2009)
  • "The role of ethnic, economic, and insurance disparities in the outcome of patients with colorectal adenocarcinoma" 11th UT Southwestern Surgical Research Forum (2009)
  • "Effect of bortezomib to enhance antitumor effects of gemcitabine and EMAP II in pancreatic cancer" American Association for Cancer Research (2009)
  • "Pancreatic cystic neoplasms: histopathologic diagnoses and resulting survival outcomes" American Hepato-Pancreato-Biliary Association 2009 Annual Meeting (2009)
  • "Proteasome inhibition in combination therapy of experimental pancreatic cancer: in vitro and in vivo evaluation" American Hepato-Pancreato-Biliary Asociation 2009 Annual Meeting (2009)
  • "Routine nasogastric decompression is unnecessary after pancreatic resection" American Hepato-Pancreato-Biliary Association 2009 Annual Meeting (2009)
  • "An antiendothelial combination strategy to increase survival in experimental pancreatic cancer" Association for Academic Surgery 4th Annual Academic Surgical Congress (2009)
  • "Impact of clinical and diagnostic characteristics on a surgical approach to retroperitoneal mass lesions" 48th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2009)
  • "Inhibition of the anti-angiogenic protein EMAP II enhances wound healing" Association for Academic Surgery 4th Annual Academic Surgical Congress (2009)
  • "Liver resection improves survival for non-metastatic gallbladder cancer: a 10 year review" 48th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2009)
  • "Operative predictors of early postgastrectomy outcomes, and their impact on long-term survival" 48th Annual Meeting of the North Texas Chapter of the American College of Surgery (2009)
  • "Operative predictors of early postgastrectomy outcomes, and their impact on long-term survival" 48th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2009)
  • "Pancreatoduodenectomy with or without pyloric preservation: a clinical outcomes comparison" Association for Academic Surgery 4th Annual Academic Surgical Congress (2009)
  • "Routine nasogastric decompression is unnecessary after pancreatic resection" 48th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2009)
  • "The role of ethnic, economic, and insurance disparities in the outcome of patients with colorectal adenocarcinoma" 48th Annual Meeting of the North Texas Chapter of the American College of Surgeons (2009)
  • "Visceral organ resections combined with synchronous major hepatectomy: feasibility and outcomes" Association for Academic Surgery 4th Annual Academic Surgical Congress (2009)
  • "Continued antiendothelial combination therapy improves long-term survival in experimental pancreatic cancer" 2009 ASCO Gastrointestinal Cancers Symposium (2009)
  • "Survival impact of malignant solid histopathologic neoplasm subtypes in the exocrine pancreas" 2009 ASCO Gastrointestinal Cancers Symposium (2009)
  • "Extended left-sided pancreatectomy with splenic vessel resection, but spleen-preservation" 10th Annual UT Southwestern Department of Surgery Surgical Research Forum (2008)
  • "Pancreatoduodenectomy with or without pyloric preservation: a clinical outcomes comparison" 10th Annual UT Southwestern Department of Surgery Surgical Research Forum (2008)
  • "Visceral organ resections combined with synchronous major hepatectomy: feasibility and outcomes" 10th Annual UT Southwestern Department of Surgery Surgical Research Forum (2008)
  • "Endothelial monocyte activating polypeptide II interferes with VEGF induced angiogenesis mechanism" American Association for Cancer Research (2008)
  • "Exploration of anti-VEGF mechanisms in experimental pancreatic cancer" American Hepato-Pancreato-Biliary Association 2008 Annual Meeting (2008)
  • "Extended left-sided pancreatectomy with spleen preservation" Association for Academic Surgery 3rd Annual Academic Surgical Congress (2008)
  • "Extended left-sided pancreatectomy with splenic vessel resection, but spleen-preservation" 47th Meeting of the American College of Surgeons, North Texas Chapter (2008)
  • "Mechanism of EMAP II-mediated inhibition of VEGF induced angiogenesis" Association for Academic Surgery 3rd Annual Academic Surgical Congress (2008)
  • "Pancreatoduodenectomy with or without pyloric preservation: a clinical outcomes comparison" 47th Annual Meeting of the American College of Surgeons, North Texas Chapter (2008)
  • "Visceral organ resections combined with synchronous major hepatectomy: feasibility and outcomes" 47th Annual Meeting of the American Colleg of Surgeons, North Texas Chapter (2008)
  • "Clinical impact of lymphadenectomy extent in resectable esophageal cancer" Digestive Disease Week (2007)
  • "The role of endoscopic ultrasound with fine-needle aspiration in guiding treatment of unusual hepatic cysts" Digestive Disease Week (2007)
  • "Enhancing gemcitabine-mediated effects against experimental pancreatic cancer via two antiangiogenic strategies" American Hepato-Pancreato-Biliary Association 2007 Annual Meeting (2007)
  • "Factors influencing perioperative blood transfusions in patients undergoing major HPB procedures" American Hepato-Pancreato-Biliary Assicuatuib 2007 /abbyak Neetubg (2007)
  • "Impact of local therapy for hepatocellular carcinoma on survival outcomes in the U.S. population" American Hepato-Pancreato-Biliary Association 2007 Annual Meeting (2007)
  • "Intrahepatic cholangiocarcinomas: treatment characteristics and results" American Hepato-Pancreato-Biliary Association 2007 Annual Meeting (2007)
  • "Factors influencing perioperative blood transfusions in patients with gastrointestinal cancer" Association for Academic Surgery 2nd Annual Academic Surgical Congress (2007)
  • "Inhibition of fibronectin-dependent pancreatic cancer proliferation through EMAP II therapy" Association for Academic Surgery 2nd Annual Academic Surgical Congress (2007)
  • "Impact of local therapy for hepatocellular carcinoma on survival outcomes in the U.S. population" 2007 ASCO Gastrointestinal Cancers Symposium (2007)
  • "Biologic effects of antiandrogenic therapy of pancreatic cancer" New Jersey Annual Retreat on Cancer Research (2006)
  • "Extent of lymph node dissection and staging for extrahepatic cholangiocarcinomas: information from a large U.S. database" 2006 Annual Meeting, American Hepato-Pancreato-Biliary Association (2006)
  • "Androgen receptor blockade in experimental combination therapy of pancreatic cancer" Association for Academic Surgery 1st Annual Academic Surgical Congress (2006)
  • "Experimental EMAP II combination therapy of pancreatic cancer targeting tumor angiogenesis" Society of University Surgeons 1st Annual Academic Surgical Congress (2006)
  • "Factors influencing change of preoperative treatment intent in patients with gastrointestinal cancer" Association for Academic Surgery 1st Annual Academic Surgical Congress (2006)
  • "Experimental combination therapy of pancreatic cancer targeting tumor angiogenesis" New Jersey Annual Retreat on Cancer Research (2005)
  • "Antiangiogenic combination treatment of experimental pancreatic cancer" 2005 ASCO Gastrointestinal Cancers Symposium (2005)
  • "Clinical impact of lymphadenectomy extent in resectable, advanced stage gastric cancer" 2005 ASCO Gastrointestinal Cancers Symposium (2005)
  • "Extent of lymphadenectomy for pancreatic cancer: information from a large U.S. database" 2005 ASCO Gastrointestinal Cancers Symposium (2005)
  • "Anticancer effects of the botanical PC-Hope extend beyond phytoestrogenic activity" 1st International Conferenceof the Society for Integrative Oncology (2004)
  • "Estrogen receptor beta / alpha ratio predicts pancreatic cancer cell response to estrogens" 38th Annual Meeting of the Association for Academic Surgery (2004)
  • "Responsiveness of pancreatic cancer cells to phytoestrogens: implications of estrogen receptor beta / alpha ratio" 1st International Conference of the Society for Integrative Oncology (2004)
  • "In vitro and in vivo efficacy of the herbal mix PC-Hope on pancreatic cancer" 95th Annual Meeting of the American Association for Cancer Research (2004)
  • "In vivo antiendothelial EMAP-II therapy in a pancreatic cancer xenotransplant model" 95th Annual Meeting of the American Association for Cancer Research (2004)
  • "In vivo monotherapy and combination treatment of pancreatic cancer with the antiendothelial agent EMAP-II" 57th Annual Cancer Symposium, Society of Surgical Oncology (2004)
  • "α5ß1 integrin and mature Endothelial-Monocyte Activating Polypeptide II interactions alter fibronectin based endothelial cell adhesion (" 6th International Symposium on Antiangiogenic Agents (2004)
  • "Chinese herbal supplement PC-Hope extending survival in pancreatic cancer model" 2004 ASCO Gastrointestinal Cancers Symposium (2004)
  • "In vivo monotherapy and combination treatment of pancreatic cancer with the antiendothelial agent EMAP-II" 2004 ASCO Gastrointestinal Cancers Sym (2004)
  • "Optimal number of lymph nodes dissected during gastrectomy for gastric cancer" 2004 ASCO Gastrointestinal Cancers Symposium (2004)
  • "Constitutive activation of Transforming Growth Factor-β Receptor signaling in human pancreatic carcinoma cells" 94th Annual Meeting of the American Association for Cancer Research (2003)
  • "PC-Hope mediated toxicity in pancreatic cancer cells: estrogenic implications" 2003 Annual Retreat on Cancer (2003)
  • "In vivo therapy of pancreatic cancer with the antiendothelial agent EMAP II" 2003Annual Retreat on Cancer Research (2003)
  • "Paint only is equivalent to scrub and paint for the preoperative preparation of breast and axillary surgery sites" 55th Annual Cancer Symposium, Society of Surgical Oncology (2002)
  • "Quality of life in patients with colorectal metastasis and intrahepatic chemotherapy" 55th Annual Cancer Symposium, Society of Surgical Oncology (2002)
  • "Challenges of interpreting non-randomized intraoperative surgical data" Graybill Conference on Linear Models (2001)
  • "Recurrence patterns after gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy" 4th International Gastric Cancer Congress (2001)
  • "Downregulation of tumor angiogenesis by antiendothelial treatment in vivo" 101st Annual Congress of the Japan Surgical Society (2001)
  • "Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease location and individual patient comorbidity" 4th International Gastric Cancer Congress (2001)
  • "Gastric carcinogenesis through tobacco chewing: in vitro mechanistic studies of DNA nitrite attack" 4th International Gastric Cancer Congress (2001)
  • "Additive toxicity through chinese herbal extracts SPES and PC-SPES in human pancreatic cancer" 92nd Annual Meeting, American Association for Cancer Research (2001)
  • "Outcome of palliative procedures for malignant bowel obstruction in patients with nongynecologic malignancy" 54th Annual Cancer Symposium, Society of Surgical Oncology (2001)
  • "Advanced age does not contribute to increased risks or poor outcome after major upper abdominal resections" American College of Surgeons Southern California Chapter Annual Meeting (2001)
  • "Resistance of human pancreatic cancer cell lines against basic fibroblast growth factor (bFGF)-mediated sensitization to cisplatin-induced cytotoxicity" International Association of Pancreatoogy and American Pancreatic Association Combined Meeting (2000)
  • "The toxic effects of Chinese herbal extracts SPES and PC-SPES on human pancreatic cancer cells" International Association of Pancreatology and American Pancreatic Association Combined Meeting (2000)
  • "Utilization and outcome of intraoperative radiation after pancreatectomy for pancreatic and periampullary cancer: a propensity score and CART analysis" International Association of Pancreatology and American Pancreatic Association Combined Meeting (2000)
  • "Gemcitabine-sensitized IORT for patients with cancer of the pancreas and other UGI sites" 2nd International Conference of the International Society of Intraoperative Radiation Therapy (2000)
  • "Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease and patient" 17th World Congress of the international Society for Digestive Surgery (2000)
  • "Gastrectomy circumstances that influence early postoperative outcome" 17th World Congress of the International Society for Digestive Surgery (2000)
  • "Preoperative platelet count predicts outcome after resection of periampullary adenocarcinoma" 17th World Congress of the International Society for Digestive Surgery (2000)
  • "The impact of intraoperative radiation on outcome after resection of periampullary adenocarcinoma" 17th World Congress of the International Society for Digestive Surgey (2000)
  • "Failure of epidermal growth factor (EGF) to sensitize human pancreatic cancer cells to cytotoxic chemotherapy" The Pancreas Club 34th Annual Meeting (2000)
  • "Intraoperative radiation for pancreatic adenocarcinoma: clinical results" The Pancreas Club 34th Annual Meeting (2000)
  • "In vitro pancreatic cancer toxicity of various chemotherapeutic agents is potentiated by wheatgerm agglutinin" 91st Annual Meeting American Association for Cancer Research (2000)
  • "In vivo therapy of local tumor progression by targeting vascular endothelium" 53rd Cancer Symposium Society of Surgical Oncology (2000)
  • "Long-term tunneled intravenous access in cancer patients: device-specific outcome" 52nd Cancer Symposium, Society of Surgical Oncology (1999)
  • "Pancreatoduodenectomies over 10 years without mortality: quality rather than quantity" Southern California Chapter of the ACS Annual Scientific Meeting (1999)
  • "The impact of splenectomy on outcome after resection of pancreatic adenocarcinoma" 39th Annual Meeting of the Society for Surgery of the Alimentary Tract (1998)
  • "Targeting p53 for adoptive T cell immunotherapy" 83rd Annual Clinical Congress, American College of Surgeons (1997)
  • "Enhanced effect of cytotoxic agents against pancreatic cancer cells in vitro through wheat germ agglutinin-induced apoptosis" American Society of Clinical Oncology Annual Meeting (1997)
  • "Gastric cancer masqueraded by metastatic breast cancer: a differential diagnostic challenge" 2nd International Gastric Cancer Congress (1997)
  • "Impact of complications on hospitalization and survival after operative treatment of gastric cancer in elderly patients" 2nd International Gastric Cancer Congress (1997)
  • "Total gastrectomy is not necessary for proximal gastric cancer" 2nd International Gastric Cancer Congress (1997)
  • "Desmoplastic small round cell tumors (DSRCT): not just some high-grade sarcomas" 50th Cancer Symposium, Society of Surgical Oncology (1997)
  • "Mechanism of wheat germ agglutinin-induced apoptosis of pancreatic cancer cells" 50th Cancer Symposium, Society of Surgical Oncology (1997)
  • "Lectin binding to pancreatic cancer cell membrane-associated carbohydrate results in toxicity and apoptosis." 82nd Annual Clinical Congress, American College of Surgeons (1996)
  • "Endothelial monocyte-activating polypeptide 2: an antiangiogenic protein suppresses tumor growth by selectively inducing apoptosis of endothelium" 1996 AACR Meeting (1996)
  • "Phythemagglutinin-L surface binding of N-linked β1-6 carbohydrates and their relationship to activated mutant ras protein in human pancreatic cancer cell lines." 1996 AACR meeting (1996)
  • "Subcutaneous central venous access devices in cancer patients" The Society of Surgical Oncology 49th Cancer Smposium (1996)
  • "Endothelial Monocyte-Activating Polypeptide (EMAP) II, a novel antiangiogenic protein, suppresses tumor growth and induces apoptosis in endothelial cells." American Heart Association, 68th Scientific Sessions (1995)
  • "A thoracoscopic approach to thoracic metastases and tumor recurrences." 48th Cancer Symposium of the Society of Surgical Oncology (1995)
  • "Inferior Vena cava filters in cancer patients: indications and outcome." The Society of Surgical Oncology 48th Cancer symposium (1995)
  • "Radiation-induced malignant tumors of the chest wall." The Society of Surgical Oncology 48th Cancer Symposium (1995)
  • "The application of thoracoscopic techniques to the management of intrathoracic metastases." European Society of Surgical Oncology Joint Meeting (1994)
  • "The application of thoracoscopic techniques to the management of intrathoracic metastases." 47th Cancer Symposium, The Society of Surgical Oncology (1994)
  • "Needle-localized thoracoscopic resections of small pulmonary nodules in patients before and after liver transplantation." 2nd Congress of the International Liver Transplantation Society (1993)
  • "Lung masses of unclear benignancy and staging: improved diagnosis and therapy with thoracoscopic resection." 110th Annual Meeting of German Surgical Society (1993)
  • "Needle-localized thoracoscopic resection of indeterminate pulmonary nodules: impact on management of patients with malignant disease." 46th Annual Cancer Meeting, Society of Surgical Oncology (1993)
  • "Experimental adoptive therapy of hepatic metastases: a comparison of systemic and locoregional administration." German Surgical Society, 107th Annual Meeting (1990)
  • "Effects of splenectomy for adoptive immunotherapy on the tumor bearing host." Association for Academic Surgery, 23rd Annual Meeting (1989)
  • "Organ-associated development of Interleukin2-induced specific immunity against mammary adenocarcinoma." 23rd Annual Meeting of the Association for Academic Surgery (1989)
  • "Regulation of Kupffer-cell-mediated antitumor activity in vitro by IL-2-activated Natural Killer cells." Society for Biological Therapy Annual Meeting (1989)
  • "Biologic properties and antitumor function of human adherent lymphokine-activated killer (A-LAK) cells." 7th International Congress of Immunology (1989)
  • "Functional analysis of antigen-receptor structures shared by natural killer (NK) cells and lymphokine-activated killer (LAK) cells." 7th International Congress of Immunology (1989)
  • "In-vitro production and serum levels of tumor necrosis factor-alpha in patients with HIV infections." 7th International Congress of Immunology (1989)
  • "Influence of previous anticancer therapy on in-vitro generation of human adherent lymphokine-activated killer (A-LAK) cells." 7th International Congress of Immunology (1989)
  • "Successful adoptive immunotherapy of established lung and liver metastases with highly purified IL-2-activated natural killer (NK) cells." International NK-Workshop (1989)
  • "Antimetastatic effects of splenectomy and lymphokine-activated killer cells purified by their adherence to plastic (A-LAK cells)." Eightieth Annual AACR Meeting (1989)
  • "Antitumor cytotoxicity and other biologic properties of human adherent lymphokine-activated killer (A-LAK) cells." Eightieth Annual AACR Meeting (1989)
  • "Factors correlated with the generation of adherent lymphokine-activated killer cells (A-LAK) in patients with metastatic melanoma and renal cell cancer." ASCO Annual Meeting (1989)
  • "A 48 kD laminin-like receptor is involved in tumor cell antigen recognition by IL-2 activated non-MHC-restricted T cells and NK cells." 73rd Annual FASEB meeting (1989)
  • "LAK cells: molecules, cells and mechanisms involved in their antitumor activity." 73rd Annual FASEB Meeting (1989)
  • "P48: a surface structure involved in target cell recognition by non-MHC-restricted cytotoxic effector cells." 4th International Conference on Leukocyte Differentiation Antigens. (1989)
  • "A sulfated glycolipid is involved in lytic interactions between non-MHC-restricted cytotoxic effector cells and their targets." 73rd Annual FASEB meeting (1989)
  • "In-vitro generation and anti-tumor cytotoxicity of adherent LAK (A-LAK) cells from the blood of patients with solid tumors." 3rd Annual Conference on Clinical Immunology, The Clinical Immunology Society (1988)
  • "A laminin B-2-chain- crossreactive surface structure (human p48 equivalent) is involved in target cell recognition by human non-MHC-restricted Interleukin-2-activated T lymphocytes." XX Annual Meeting of the "Gesellschaft fur Immunologie" (1988)
  • "Generation of LAK cell activity and enrichment in the most active, plastic adherent (A-LAK) effector cells in patients with malignant liver tumors." Ninth European Immunology Meeting (1988)
  • "Enhanced antimetastatic efficacy of lymphokine activated killer cells purified by their adherance to plastic (A-LAK cells)." Annual FASEB-Meeting (1988)
  • "Enhanced in vivo and in vitro antitumor efficacy of highly purified plastic adherent lymphokine activated killer cells (ALAK cells)." AACR (1988)
  • "Functional and phenotypic analysis of tumor infiltrating lymphocytes isolated from human liver tumors and cultured in rIL-2." Annual FASEB-Meeting (1988)
  • "Functional and phenotypic characteristics of adherent lymphokine-activated killer (A-LAK) cells from patients with malignant liver and central nervous system (CNS) tumors." 19th International Leukocyte Culture Conference (1988)
  • "Laminin B2 chain (p48 protein) is involved in tumor cell recognition by both Leu19+/CD3- and Leu19+/CD3- lymphokine-activated killer cells." 19th International Leukocyte Culture Conference (1988)
  • "The generation of purified adherent lymphokine-activated killer (ALAK) cells in patients with benign and malignant liver tumors." Annual FASEB-Meeting (1988)
  • "The laminin B2 chain (p48 protein): A functional role in cytotoxicity by highly purified Leu19+ human NK/LAK cells." V. Annual NK-Workshop (1988)
  • "Enhanced anti-metastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic." Ninth European Immunology Meeting (1988)
  • "Role of laminin B2 chain (p48 protein) in tumor cell recognition by highly purified Leu19+ lymphokine activated killer cells." Annual FASEB-Meeting (1988)
  • "The influence of laminin and anti-laminin on cytolytic function and proliferation of NK and LAK cells." Ninth European Immunology Meeting (1988)
  • "Tumor necrosis factor-alpha serum levels and in vitro production in patients with HIV infection" 73rd Annual FASEB meeting (1987)
See all (211 more)

School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information

Roswell Park Cancer Institute
Elm and Carlton Streets
Buffalo, NY 14263
Phone: (214) 537-0498
roderich@buffalo.edu